Literature DB >> 17602068

Shortening the infusion time of anticancer drugs: who will benefit?

Kim Margolin, Michael Gordon.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17602068     DOI: 10.1200/JCO.2007.10.7334

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Cerebrovascular events after bevacizumab treatment: an early and severe complication.

Authors:  Raymond C S Seet; Alejandro A Rabinstein; Paul E Lindell; Joon H Uhm; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.